Addiction Related Content

Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, including for developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site...

Shelly F. Greenfield, MD, MPH, is an addiction psychiatrist, clinician, and researcher. She serves as principal and co-investigator on federally funded research focusing on substance use disorders treatment, gender differences, and substance health services. She received a National Institute on Drug...

Staci Gruber, PhD, is the director of the Cognitive and Clinical Neuroimaging Core and the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital. She is an associate professor of psychiatry at Harvard Medical School. Her research focuses on the application of...

Hilary S. Connery, MD, PhD, is an assistant professor of psychiatry at Harvard Medical School and serves as the clinical director for McLean Hospital’s Division of Alcohol, Drugs, and Addiction. Dr. Connery’s expertise includes treatment of opioid use disorders and integrated treatments for co...

Miles G. Cunningham, MD, PhD, earned a PhD in 1993 from Massachusetts Institute of Technology, specializing in “Transplantation Strategies for the Analysis of Brain Development and Repair.” He earned an MD in 1995 from Harvard Medical School, with a special interest in neuropsychiatry and behavioral...

Marc L. Copersino, PhD, ABPP-CP, is affiliated with the Division of Alcohol, Drugs, and Addiction and works collaboratively with members of the McLean Imaging Center. He conducts patient-oriented research focusing on the clinical neuroscience and treatment of substance use disorders (SUD) in two...

Anna W. Sromek, PhD, received her BS in chemistry at the University of Chicago in 1996, and PhD in organic chemistry at the University of Illinois at Chicago in 2005. She was a NIDA post-doctoral research fellow at McLean Hospital from 2008 to 2010, and a recipient of the Alfred Pope Award for Young...

Dr. Lin is currently a grantee of both NIH and Fulbright, with a long-term interest in reducing the prevalence of substance abuse around the world. Dr. Lin’s research focuses on delineation of environmentally related genomic risks for substance abuse, through mapping out molecular pathways that...

James I. Hudson, MD, ScD, SM, received his MD from Tufts University Medical School of Medicine and his ScD and SM degrees from Harvard School of Public Health. Joining McLean Hospital in 1980, he is currently a professor of psychiatry at Harvard Medical School, and director of the Biological...

Bertha K. Madras, PhD, is a professor of psychobiology at Harvard Medical School, based at McLean Hospital and cross appointed at the Massachusetts General Hospital. Her research focuses on neurobiology, imaging, and medications development (19 U.S. and 27 international patents) for neuropsychiatric...

Jennifer T. Sneider, PhD, focuses her research on the role of the hippocampus, with a particular interest in characterizing sex differences and the role of the menstrual cycle on hippocampal-based memory function. She has received funding from the National Institute on Drug Abuse to apply magnetic...

Julia E. Cohen-Gilbert, PhD, employs cognitive and behavioral measures in conjunction with magnetic resonance imaging and magnetic resonance spectroscopy to investigate the role of brain development in cognitive and emotional regulation during adolescence. She is particularly interested in dynamic...

Jessica Feinberg, LICSW, came to McLean after completing a clinical fellowship at the Yale Child Study Center. She has worked as a therapist and clinical social worker in the Adolescent Acute Residential Treatment (ART) Program since 2002. Ms. Feinberg is trained in dialectical behavior therapy and...

Ruth Reibstein, EdD, is a staff psychologist for the Alcohol, Drug, and Addiction Partial Hospital Program at McLean Hospital. She is also an instructor in psychology in the Department of Psychiatry at Harvard Medical School. Dr. Reibstein’s primary interests include integrated treatment for...

R. Kathryn McHugh, PhD, engages in clinical and translational research focusing on the nature and treatment of anxiety and addiction. She is particularly interested in the study of affective vulnerability factors, such as distress intolerance and stress reactivity, that are common across...

Dawn E. Sugarman, PhD, is a research psychologist in the Division of Alcohol, Drugs, and Addiction at McLean Hospital. Dr. Sugarman focuses her research and clinical work on the treatment of addictive behaviors. She is particularly interested in gender-specific treatment for substance use disorders...

Marisa M. Silveri, PhD, has been studying the neurobiology of brain development and consequences of alcohol and drug abuse using preclinical and clinical models for over two decades. Her current work uses non-invasive magnetic resonance techniques to examine brain structure, function, and...

Rocco A. Iannucci, MD, began his psychiatric career at Massachusetts General Hospital and McLean Hospital, where he served as chief resident in addiction psychiatry and as assistant director of psychiatric residency training. In 2008, he entered a practice at the Berkshire Medical Center, serving as...

Dr. Kaufman is director of McLean Hospital’s Translational Imaging Laboratory, associate professor of psychiatry at Harvard Medical School, co-director of the NIDA T32 post-doctoral training program at McLean, and a Partners Human Research Committee member. He conducts translational research in...

Bill Carlezon, PhD, has received several awards for his research, including an Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD), the Presidential Early Career Award for Scientists and Engineers (PECASE) from George W. Bush, and the Jacob...